BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24997250)

  • 1. Antiviral drugs specific for coronaviruses in preclinical development.
    Adedeji AO; Sarafianos SG
    Curr Opin Virol; 2014 Oct; 8():45-53. PubMed ID: 24997250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL
    Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH
    Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
    Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
    de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative screening approaches for discovery of Middle East respiratory syndrome coronavirus inhibitors.
    LaFemina RL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4251-2. PubMed ID: 24867994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valinomycin as a potential antiviral agent against coronaviruses: A review.
    Zhang D; Ma Z; Chen H; Lu Y; Chen X
    Biomed J; 2020 Oct; 43(5):414-423. PubMed ID: 33012699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus.
    Cheng KW; Cheng SC; Chen WY; Lin MH; Chuang SJ; Cheng IH; Sun CY; Chou CY
    Antiviral Res; 2015 Mar; 115():9-16. PubMed ID: 25542975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of heterocyclic compounds in SARS and SARS CoV-2 pandemic.
    Negi M; Chawla PA; Faruk A; Chawla V
    Bioorg Chem; 2020 Nov; 104():104315. PubMed ID: 33007742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
    Shen L; Niu J; Wang C; Huang B; Wang W; Zhu N; Deng Y; Wang H; Ye F; Cen S; Tan W
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and Nature-Derived Products Targeting Human Coronaviruses.
    Vougogiannopoulou K; Corona A; Tramontano E; Alexis MN; Skaltsounis AL
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes.
    Lin MH; Moses DC; Hsieh CH; Cheng SC; Chen YH; Sun CY; Chou CY
    Antiviral Res; 2018 Feb; 150():155-163. PubMed ID: 29289665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.
    Li C; Chu H; Liu X; Chiu MC; Zhao X; Wang D; Wei Y; Hou Y; Shuai H; Cai J; Chan JF; Zhou J; Yuen KY
    Emerg Microbes Infect; 2020 Dec; 9(1):2663-2672. PubMed ID: 33179566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.